Dr. Reddy’s Laboratories Announces Science-Based Net Zero Climate Targets
Dr. Reddy’s Laboratories Ltd. has announced its Net Zero with near-term and long-term science-based emissions reduction targets, approved by the Science Based Targets initiative (SBTi). The company commits to achieving Net Zero greenhouse gas emissions across its value chain by FY2045. In the near term, the company commits to reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 80%, and Scope 3 emissions by 51.6% per INR value added by FY2030, using FY2023 as the base year. In the long term, it commits to reducing absolute Scope 1, 2, and 3 emissions by 90% by FY2045, again from the FY2023 baseline. Dr. Reddy’s is the only company in India’s pharmaceutical sector to commit to a science-based Net Zero target by FY2045.
Key Highlights
- Dr. Reddy’s has announced science-based Net Zero climate targets.
- The company commits to achieving Net Zero greenhouse gas emissions across its value chain by FY2045.
- Dr. Reddy’s is the only company in India’s pharmaceutical sector to commit to a science-based Net Zero target by FY2045.
- The company has revised its near-term SBTi targets to Net Zero, in line with the latest SBTi Framework.
- Dr. Reddy’s is on track to achieve coal- and furnace oil-free operations by the end of FY’26, with 68% of its power in FY’25 sourced from renewables.